Ocular Therapeutix, Inc.
US ˙ NasdaqGM ˙ US67576A1007

SecurityOCUL / Ocular Therapeutix, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership635,922 shares
Latest Disclosed Value $ 5,386,259
Citadel Advisors Llc ownership in OCUL / Ocular Therapeutix, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 635,922 shares of Ocular Therapeutix, Inc. (US:OCUL) valued at $5,386,259 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,475,849 shares of Ocular Therapeutix, Inc.. This represents a change in shares of -74.31% during the quarter. The current value of the position is $5,246,356 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (OCUL) in the form of stock options. The firm currently holds call options representing 398,800 of underlying shares valued at $3,377,836 USD and put options representing 94,000 of underlying shares valued at $796,180 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

OCUL / Ocular Therapeutix, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OCULAR THERAPEUTIX COM 67576A100 635,922 -1,839,927 -74.31 5,386 -82.08 0.0008
2026-02-17 2025-12-31 13F OCULAR THERAPEUTIX COM 67576A100 2,475,849 -3,227,932 -56.59 30,057 -54.92 0.0045
2025-11-14 2025-09-30 13F OCULAR THERAPEUTIX COM 67576A100 5,703,781 817,767 16.74 66,677 47.05 0.0101
2025-08-14 2025-06-30 13F OCULAR THERAPEUTIX COM 67576A100 4,886,014 74,906 1.56 45,342 28.58 0.0079
2025-05-15 2025-03-31 13F OCULAR THERAPEUTIX COM 67576A100 4,811,108 354,298 7.95 35,265 -7.35 0.0067
2025-02-14 2024-12-31 13F OCULAR THERAPEUTIX COM 67576A100 4,456,810 196,972 4.62 38,061 2.70 0.0066
2024-11-14 2024-09-30 13F OCULAR THERAPEUTIX COM 67576A100 4,259,838 205,976 5.08 37,061 33.66 0.0072
2024-08-14 2024-06-30 13F OCULAR THERAPEUTIX COM 67576A100 4,053,862 -1,366,739 -25.21 27,728 -42.73 0.0056
2024-05-15 2024-03-31 13F OCULAR THERAPEUTIX COM 67576A100 5,420,601 1,884,592 53.30 48,420 207.03 0.0093
2024-02-14 2023-12-31 13F OCULAR THERAPEUTIX COM 67576A100 3,536,009 2,246,653 174.25 15,771 289.58 0.0032
2023-11-14 2023-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,289,356 39,605 3.17 4,049 -37.22 0.0009
2023-08-14 2023-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,249,751 -276,521 -18.12 6,449 -19.83 0.0013
2023-05-15 2023-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,526,272 -421,464 -21.64 8,043 46.96 0.0018
2023-02-14 2022-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,947,736 555,311 39.88 5,473 -5.30 0.0013
2022-11-14 2022-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,392,425 -331,568 -19.23 5,779 -16.61 0.0013
2022-08-15 2022-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,723,993 31,657 1.87 6,930 -17.27 0.0018
2022-05-16 2022-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,692,336 161,314 10.54 8,377 -21.50 0.0017
2022-02-14 2021-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,531,022 1,487,417 3,411.12 10,671 2,347.48 0.0022
2021-11-15 2021-09-30 13F OCULAR THERAPEUTIX Cmn 67576A100 43,605 -108,645 -71.36 436 -79.81 0.0001
2021-08-16 2021-06-30 13F OCULAR THERAPEUTIX COM 67576A100 152,250 44,169 40.87 2,159 21.70 0.0005
2021-05-21 2021-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 108,081 -1,480,793 -93.20 1,774 -94.61 0.0004
2021-05-17 2021-03-31 13F OCULAR THERAPEUTIX COM 67576A100 108,081 -1,480,793 1,774 0.0004
2021-02-16 2020-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,588,874 -33,089 -2.04 32,889 166.46 0.0086
2020-11-16 2020-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,621,963 1,401,694 636.36 12,343 572.64 0.0035
2020-08-14 2020-06-30 13F OCULAR THERAPEUTIX Cmn 67576A100 220,269 161,032 271.84 1,835 524.15 0.0007
2020-05-15 2020-03-31 13F OCULAR THERAPEUTIX Cmn 67576A100 59,237 27,410 86.12 294 133.33 0.0001
2020-02-14 2019-12-31 13F OCULAR THERAPEUTIX Cmn 67576A100 31,827 13,573 74.36 126 129.09 0.0001
2019-11-14 2019-09-30 13F OCULAR THERAPEUTIX Cmn 67576A100 18,254 -1,966 -9.72 55 -38.20 0.0000
2019-08-14 2019-06-30 13F OCULAR THERAPEUTIX Cmn 67576A100 20,220 -5,884 -22.54 89 -14.42 0.0000
2019-05-15 2019-03-31 13F OCULAR THERAPEUTIX Cmn 67576A100 26,104 -38,602 -59.66 104 -59.69 0.0001
2019-02-14 2018-12-31 13F OCULAR THERAPEUTIX Cmn 67576A100 64,706 39,940 161.27 258 51.76 0.0001
2018-11-13 2018-09-30 13F OCULAR THERAPEUTIX Cmn 67576A100 24,766 4,330 21.19 170 23.19 0.0001
2018-08-14 2018-06-30 13F/A-1 OCULAR THERAPEUTIX Cmn 67576A100 20,436 20,436 138 0.0001
2018-08-10 2018-06-30 13F OCULAR THERAPEUTIX Cmn 67576A100 20,436 20,436 138
2018-05-14 2018-03-31 13F/A-1 OCULAR THERAPEUTIX Cmn 67576A100 0 -11,589 -100.00 0 -100.00
2018-02-09 2017-12-31 13F OCULAR THERAPEUTIX Cmn 67576A100 11,589 11,589 52 0.0000
2016-11-10 2016-09-30 13F OCULAR THERAPEUTIX Cmn 67576A100 0 -57,791 -100.00 0 -100.00
2017-01-31 2016-06-30 13F/A-1 OCULAR THERAPEUTIX Cmn 67576A100 57,791 57,791 0.00 286 0.0003
2016-08-12 2016-06-30 13F OCULAR THERAPEUTIX Cmn 67576A100 57,791 286
2016-05-13 2016-03-31 13F OCULAR THERAPEUTIX Cmn 67576A100 0 -9,542 -100.00 0 -100.00
2017-01-31 2015-12-31 13F/A-1 OCULAR THERAPEUTIX Cmn 67576A100 9,542 9,542 -46.04 89 -76.08 0.0001
2016-02-12 2015-12-31 13F OCULAR THERAPEUTIX Cmn 67576A100 9,542 89
2015-11-16 2015-09-30 13F OCULAR THERAPEUTIX Cmn 67576A100 0 -17,682 -100.00 0 -100.00
2015-08-14 2015-06-30 13F OCULAR THERAPEUTIX Cmn 67576A100 17,682 17,682 372 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F OCULAR THERAPEUTIX COM Call 398,800 14.01 3,378 -20.47 n/a n/a n/a
2026-02-17 2025-12-31 13F OCULAR THERAPEUTIX COM Call 349,800 68.58 4,247 75.09 n/a n/a n/a
2025-11-14 2025-09-30 13F OCULAR THERAPEUTIX COM Call 207,500 62.24 2,426 104.47 n/a n/a n/a
2025-08-14 2025-06-30 13F OCULAR THERAPEUTIX COM Call 127,900 -8.58 1,187 15.71 n/a n/a n/a
2025-05-15 2025-03-31 13F OCULAR THERAPEUTIX COM Call 139,900 21.55 1,025 4.38 n/a n/a n/a
2025-02-14 2024-12-31 13F OCULAR THERAPEUTIX COM Call 115,100 194.37 983 188.82 n/a n/a n/a
2024-11-14 2024-09-30 13F OCULAR THERAPEUTIX COM Call 39,100 198.47 340 282.02 n/a n/a n/a
2024-08-14 2024-06-30 13F OCULAR THERAPEUTIX COM Call 13,100 -61.36 90 -71.10 n/a n/a n/a
2024-05-15 2024-03-31 13F OCULAR THERAPEUTIX COM Call 33,900 -21.35 308 60.42 n/a n/a n/a
2024-02-14 2023-12-31 13F OCULAR THERAPEUTIX COM Call 43,100 -1.82 192 40.15 n/a n/a n/a
2023-11-14 2023-09-30 13F OCULAR THERAPEUTIX COM Call 43,900 -51.06 138 -70.35 n/a n/a n/a
2023-08-14 2023-06-30 13F OCULAR THERAPEUTIX COM Call 89,700 -72.79 463 -73.40 n/a n/a n/a
2023-05-15 2023-03-31 13F OCULAR THERAPEUTIX COM Call 329,700 357.28 1,738 759.90 n/a n/a n/a
2023-02-14 2022-12-31 13F OCULAR THERAPEUTIX COM Call 72,100 4.04 203 -29.86 n/a n/a n/a
2022-11-14 2022-09-30 13F OCULAR THERAPEUTIX COM Call 69,300 437.21 288 453.85 n/a n/a n/a
2022-08-15 2022-06-30 13F OCULAR THERAPEUTIX COM Call 12,900 -52.75 52 -61.48 n/a n/a n/a
2022-05-16 2022-03-31 13F OCULAR THERAPEUTIX COM Call 27,300 -75.05 135 -82.31 n/a n/a n/a
2022-02-14 2021-12-31 13F OCULAR THERAPEUTIX COM Call 109,400 -59.51 763 -71.76 n/a n/a n/a
2021-11-15 2021-09-30 13F OCULAR THERAPEUTIX Cmn Call 270,200 41.47 2,702 -0.22 n/a n/a n/a
2021-08-16 2021-06-30 13F OCULAR THERAPEUTIX COM Call 191,000 381.11 2,708 315.98 n/a n/a n/a
2021-05-21 2021-03-31 13F/A OCULAR THERAPEUTIX COM Call 39,700 28.90 651 2.04 n/a n/a n/a
2021-05-17 2021-03-31 13F OCULAR THERAPEUTIX COM Call 39,700 651 n/a n/a n/a
2021-02-16 2020-12-31 13F OCULAR THERAPEUTIX COM Call 30,800 22.71 638 234.03 n/a n/a n/a
2020-11-16 2020-09-30 13F OCULAR THERAPEUTIX COM Call 25,100 -34.81 191 -40.50 n/a n/a n/a
2020-08-14 2020-06-30 13F OCULAR THERAPEUTIX Cmn Call 38,500 14.58 321 93.37 n/a n/a n/a
2020-05-15 2020-03-31 13F OCULAR THERAPEUTIX Cmn Call 33,600 147.06 166 207.41 n/a n/a n/a
2020-02-14 2019-12-31 13F OCULAR THERAPEUTIX Cmn Call 13,600 -43.80 54 -27.03 n/a n/a n/a
2019-11-14 2019-09-30 13F OCULAR THERAPEUTIX Cmn Call 24,200 -0.41 74 -30.84 n/a n/a n/a
2019-08-14 2019-06-30 13F OCULAR THERAPEUTIX Cmn Call 24,300 -22.36 107 -13.71 n/a n/a n/a
2019-05-15 2019-03-31 13F OCULAR THERAPEUTIX Cmn Call 31,300 124 n/a n/a n/a
2019-02-14 2018-12-31 13F OCULAR THERAPEUTIX Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F OCULAR THERAPEUTIX Cmn Call 36,600 60.53 252 63.64 n/a n/a n/a
2018-08-14 2018-06-30 13F/A OCULAR THERAPEUTIX Cmn Call 22,800 15.15 154 19.38 n/a n/a n/a
2018-08-10 2018-06-30 13F OCULAR THERAPEUTIX Cmn Call 22,800 154 n/a n/a n/a
2018-05-14 2018-03-31 13F/A OCULAR THERAPEUTIX Cmn Call 19,800 81.65 129 163.27 n/a n/a n/a
2018-05-11 2018-03-31 13F OCULAR THERAPEUTIX Cmn Call 19,800 129 n/a n/a n/a
2018-02-09 2017-12-31 13F OCULAR THERAPEUTIX Cmn Call 10,900 -55.87 49 -67.97 n/a n/a n/a
2017-11-09 2017-09-30 13F OCULAR THERAPEUTIX Cmn Call 24,700 -40.77 153 -60.47 n/a n/a n/a
2017-08-11 2017-06-30 13F OCULAR THERAPEUTIX Cmn Call 41,700 77.45 387 77.52 n/a n/a n/a
2017-05-12 2017-03-31 13F OCULAR THERAPEUTIX Cmn Call 23,500 16.34 218 28.99 n/a n/a n/a
2017-02-10 2016-12-31 13F OCULAR THERAPEUTIX Cmn Call 20,200 169 n/a n/a n/a
2017-01-31 2016-06-30 13F/A OCULAR THERAPEUTIX Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2016-03-31 13F/A OCULAR THERAPEUTIX Cmn Call 13,400 1,388.89 129 1,512.50 n/a n/a n/a
2016-05-13 2016-03-31 13F OCULAR THERAPEUTIX Cmn Call 13,400 129 n/a n/a n/a
2017-01-31 2015-12-31 13F/A OCULAR THERAPEUTIX Cmn Call 900 8 n/a n/a n/a
2016-02-12 2015-12-31 13F OCULAR THERAPEUTIX Cmn Call 900 8 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F OCULAR THERAPEUTIX COM Put 94,000 12.04 796 -21.81 n/a n/a n/a
2026-02-17 2025-12-31 13F OCULAR THERAPEUTIX COM Put 83,900 112.41 1,019 120.82 n/a n/a n/a
2025-11-14 2025-09-30 13F OCULAR THERAPEUTIX COM Put 39,500 -26.31 462 -7.24 n/a n/a n/a
2025-08-14 2025-06-30 13F OCULAR THERAPEUTIX COM Put 53,600 -12.85 497 10.44 n/a n/a n/a
2025-05-15 2025-03-31 13F OCULAR THERAPEUTIX COM Put 61,500 -38.31 451 -47.12 n/a n/a n/a
2025-02-14 2024-12-31 13F OCULAR THERAPEUTIX COM Put 99,700 -0.20 851 -2.07 n/a n/a n/a
2024-11-14 2024-09-30 13F OCULAR THERAPEUTIX COM Put 99,900 -23.74 869 -3.01 n/a n/a n/a
2024-08-14 2024-06-30 13F OCULAR THERAPEUTIX COM Put 131,000 -27.94 896 -45.83 n/a n/a n/a
2024-05-15 2024-03-31 13F OCULAR THERAPEUTIX COM Put 181,800 262.87 1,654 641.70 n/a n/a n/a
2024-02-14 2023-12-31 13F OCULAR THERAPEUTIX COM Put 50,100 78.93 223 156.32 n/a n/a n/a
2023-11-14 2023-09-30 13F OCULAR THERAPEUTIX COM Put 28,000 -83.55 88 -90.09 n/a n/a n/a
2023-08-14 2023-06-30 13F OCULAR THERAPEUTIX COM Put 170,200 42.91 878 40.03 n/a n/a n/a
2023-05-15 2023-03-31 13F OCULAR THERAPEUTIX COM Put 119,100 138.68 628 347.86 n/a n/a n/a
2023-02-14 2022-12-31 13F OCULAR THERAPEUTIX COM Put 49,900 70.31 140 14.75 n/a n/a n/a
2022-11-14 2022-09-30 13F OCULAR THERAPEUTIX COM Put 29,300 122 n/a n/a n/a
2022-05-16 2022-03-31 13F OCULAR THERAPEUTIX COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F OCULAR THERAPEUTIX COM Put 23,300 -48.68 162 -64.32 n/a n/a n/a
2021-11-15 2021-09-30 13F OCULAR THERAPEUTIX Cmn Put 45,400 -17.15 454 -41.57 n/a n/a n/a
2021-08-16 2021-06-30 13F OCULAR THERAPEUTIX COM Put 54,800 -19.17 777 -30.19 n/a n/a n/a
2021-05-21 2021-03-31 13F/A OCULAR THERAPEUTIX COM Put 67,800 -2.45 1,113 -22.65 n/a n/a n/a
2021-05-17 2021-03-31 13F OCULAR THERAPEUTIX COM Put 67,800 1,113 n/a n/a n/a
2021-02-16 2020-12-31 13F OCULAR THERAPEUTIX COM Put 69,500 114.51 1,439 482.59 n/a n/a n/a
2020-11-16 2020-09-30 13F OCULAR THERAPEUTIX COM Put 32,400 31.17 247 19.90 n/a n/a n/a
2020-08-14 2020-06-30 13F OCULAR THERAPEUTIX Cmn Put 24,700 22.89 206 108.08 n/a n/a n/a
2020-05-15 2020-03-31 13F OCULAR THERAPEUTIX Cmn Put 20,100 35.81 99 70.69 n/a n/a n/a
2020-02-14 2019-12-31 13F OCULAR THERAPEUTIX Cmn Put 14,800 -35.93 58 -17.14 n/a n/a n/a
2019-11-14 2019-09-30 13F OCULAR THERAPEUTIX Cmn Put 23,100 5.96 70 -27.08 n/a n/a n/a
2019-08-14 2019-06-30 13F OCULAR THERAPEUTIX Cmn Put 21,800 20.44 96 33.33 n/a n/a n/a
2019-05-15 2019-03-31 13F OCULAR THERAPEUTIX Cmn Put 18,100 -2.69 72 -2.70 n/a n/a n/a
2019-02-14 2018-12-31 13F OCULAR THERAPEUTIX Cmn Put 18,600 78.85 74 2.78 n/a n/a n/a
2018-11-13 2018-09-30 13F OCULAR THERAPEUTIX Cmn Put 10,400 72 n/a n/a n/a
2017-11-09 2017-09-30 13F OCULAR THERAPEUTIX Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-11 2017-06-30 13F OCULAR THERAPEUTIX Cmn Put 11,000 -28.57 102 -28.67 n/a n/a n/a
2017-05-12 2017-03-31 13F OCULAR THERAPEUTIX Cmn Put 15,400 143 n/a n/a n/a
2017-02-10 2016-12-31 13F OCULAR THERAPEUTIX Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2016-09-30 13F/A OCULAR THERAPEUTIX Cmn Put 10,600 73 n/a n/a n/a
2016-11-10 2016-09-30 13F OCULAR THERAPEUTIX Cmn Put 10,600 73 n/a n/a n/a
2016-05-13 2016-03-31 13F OCULAR THERAPEUTIX Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-01-31 2015-12-31 13F/A OCULAR THERAPEUTIX Cmn Put 1,400 13 n/a n/a n/a
2016-02-12 2015-12-31 13F OCULAR THERAPEUTIX Cmn Put 1,400 13 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.